Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection
Cole J. Batty, Mark T. Heise, Eric M. Bachelder, Kristy M. Ainslie
Topics & Concepts
Clinical trialPandemicMedicineCoronavirusCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicine2019-20 coronavirus outbreakVaccinationImmunologyVirologyOutbreakInfectious disease (medical specialty)DiseasePathologySARS-CoV-2 and COVID-19 ResearchImmunotherapy and Immune ResponsesVaccine Coverage and Hesitancy